What kind of changes happen to vessels when the pH of blood reduces?

Choice A: Excretion

Excretion is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine), but also via bile, sweat, saliva, and other routes. While excretion is a crucial phase of pharmacokinetics, it is not directly impacted by the first pass effect. The first pass effect primarily involves the metabolism of a drug before it reaches systemic circulation, which occurs prior to the excretion phase.

Choice B: Metabolism

The first pass effect, also known as first-pass metabolism or presystemic metabolism, significantly impacts the metabolism phase of pharmacokinetics. This phenomenon occurs when a drug is metabolized at a specific location in the body, such as the liver or gut wall, before it reaches systemic circulation. As a result, the concentration of the active drug is reduced, affecting its bioavailability. The liver is the primary site for this metabolic process, where enzymes break down the drug, potentially leading to a significant reduction in its therapeutic effect.

Choice C: Distribution

Distribution refers to the process by which a drug is transported from the bloodstream to various tissues and organs in the body. This phase is influenced by factors such as blood flow, tissue permeability, and binding to plasma proteins. However, the first pass effect does not directly alter the distribution phase. Instead, it affects the amount of drug that enters systemic circulation, which in turn can influence the extent of distribution.

Choice D: Absorption

Absorption is the process by which a drug enters the bloodstream from its site of administration. This phase is crucial for determining the onset of a drug’s action. While the first pass effect occurs after absorption, it does not directly change the absorption phase itself. Instead, it affects the drug’s concentration after it has been absorbed and before it reaches systemic circulation.

Choice A Reason:

The prodromal stage refers to the period during which early symptoms of a disease appear but are not yet specific or severe. This stage is often associated with infectious diseases where initial symptoms like fever, malaise, and fatigue occur before more specific symptoms develop. In the context of HIV, the prodromal stage would not be applicable as it refers to the early symptomatic phase rather than a period without symptoms.

Choice B Reason:

Remission is a term used to describe a period during which the symptoms of a disease are reduced or disappear. This term is commonly used in the context of chronic diseases such as cancer or autoimmune disorders. For HIV, remission would imply a reduction in viral load and symptoms due to effective treatment, but it does not describe the asymptomatic phase following initial exposure.

Choice C Reason:

Exacerbation refers to the worsening or flare-up of symptoms in a chronic disease. This term is often used in conditions like asthma or multiple sclerosis where symptoms can become more severe periodically. In the context of HIV, exacerbation would describe periods where symptoms become more pronounced, not the asymptomatic phase after initial exposure.

Choice D Reason:

The latent stage, also known as the clinical latency stage or asymptomatic HIV infection, is the period after initial HIV exposure when the virus is present in the body but not causing any symptoms. During this stage, HIV continues to replicate at low levels, and the individual may not feel sick or show any signs of the disease. This stage can last for several years, especially with effective antiretroviral therapy.